Alkermes (ALKS) Price to Sales (2010 - 2026)

Alkermes (ALKS) Price to Sales (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) P/S
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 2.29
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 3.64
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 7.59
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 63.60
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 5.36
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 2.49
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 6.10
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.79
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 4.18
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 19.59

Historic Data

Download Data
DateValue
Jun 9, 2026 6.10
Jun 8, 2026 5.84
Jun 5, 2026 5.88
Jun 4, 2026 5.96
Jun 3, 2026 5.88
Jun 2, 2026 5.68
Jun 1, 2026 5.81
May 29, 2026 5.80
May 28, 2026 5.49
May 27, 2026 5.24
May 26, 2026 5.13
May 22, 2026 5.06
May 21, 2026 5.08
May 20, 2026 5.09
May 19, 2026 5.09
May 18, 2026 5.11
May 15, 2026 5.15
May 14, 2026 5.28
May 13, 2026 5.35
May 12, 2026 5.26